Your session is about to expire
← Back to Search
Photographs for Down Syndrome
N/A
Recruiting
Led By Kevin Cleary, PhD
Research Sponsored by Kevin Cleary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights
Study Summary
This trial is investigating a new method to detect Down syndrome using facial characteristics. If successful, the technology could be used to help detect other disorders.
Eligible Conditions
- Down Syndrome
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Down Syndrome
Secondary outcome measures
Number of participants with other dysmorphic syndromes accurately assessed by computer-aided detection (CADe) tool
Trial Design
2Treatment groups
Active Control
Group I: Down syndromeActive Control1 Intervention
photographs of individuals less than 18 yo with Down syndrome
Group II: Control groupActive Control1 Intervention
photographs of individuals less than 18 yo with a genetic referral (not Down syndrome) or a healthy sibling to a child with Down syndrome
Find a Location
Who is running the clinical trial?
Kevin ClearyLead Sponsor
Children's National Research InstituteOTHER
210 Previous Clinical Trials
207,007 Total Patients Enrolled
George Washington UniversityOTHER
243 Previous Clinical Trials
453,024 Total Patients Enrolled
2 Trials studying Down Syndrome
21,897 Patients Enrolled for Down Syndrome
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- A child with Down syndrome.Healthy brothers or sisters of a child with Down syndrome, or other people with a genetic condition who are being compared to the study participants, are not eligible to participate in the study.
Research Study Groups:
This trial has the following groups:- Group 1: Down syndrome
- Group 2: Control group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is registration for this experiment still available to potential participants?
"Affirmative. Clinicaltrials.gov records confirm that this experimental trial, which was first advertised on February 1st 2013, is currently recruiting participants. 750 people must be recruited from a single medical site."
Answered by AI
What is the current enrollment demographic for this clinical experiment?
"Affirmative, the clinical trial is actively recruiting participants. It was initially posted on February 1st 2013 and has since been updated on April 2nd 2021. A total of 750 individuals are being required to register at a single research centre."
Answered by AI
Share this study with friends
Copy Link
Messenger